어비디티 바이오사이언스 (RNA)

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Dyne Therapeutics, miRecule, Avidity Biosciences, aTyr Pharma, Fulcrum Therapeutics - Barchart.com

Feb 13, 2026

Feb 13, 2026

Facioscapulohumeral Muscular Dystrophy Market: High-Growth - openPR.com

Feb 13, 2026

Feb 11, 2026

Does Avidity Biosciences Inc. have strong EBITDA marginsJuly 2025 Trends & Free High Return Stock Watch Alerts - mfd.ru

Feb 11, 2026

Feb 11, 2026

Is Avidity Biosciences Inc. stock near bottom after declineProduct Launch & Detailed Earnings Play Alerts - mfd.ru

Feb 11, 2026

Feb 11, 2026

Why Avidity Biosciences Inc. stock is recommended by analystsJuly 2025 Chart Watch & Smart Investment Allocation Tips - mfd.ru

Feb 11, 2026

Feb 10, 2026

Volume Report: How does Avidity Biosciences Inc compare to its peersAnalyst Downgrade & Expert Approved Momentum Trade Ideas - baoquankhu1.vn

Feb 10, 2026

Feb 10, 2026

Avidity Biosciences, Inc. $RNA Shares Acquired by Candriam S.C.A. - MarketBeat

Feb 10, 2026

Feb 06, 2026

Avidity Biosciences prices $600M stock offering - MSN

Feb 06, 2026

Feb 04, 2026

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Avidity Biosciences (RNA) - The Globe and Mail

Feb 04, 2026

Feb 04, 2026

(RNA) and the Role of Price-Sensitive Allocations - Stock Traders Daily

Feb 04, 2026

Feb 03, 2026

Key facts: JPMorgan raises concerns on Novartis outlook; Novartis to acquire Avidity - TradingView

Feb 03, 2026

Feb 03, 2026

Avidity Biosciences Announces Expected Record Date for Spin-Off - TradingView

Feb 03, 2026

Feb 03, 2026

Avidity Biosciences stock hits all-time high at 72.74 USD By Investing.com - Investing.com Australia

Feb 03, 2026

Feb 03, 2026

Avidity Biosciences receives FTC clearance for Novartis merger - MSN

Feb 03, 2026

Feb 03, 2026

Novartis (NVS) Acquisition of Avidity Biosciences Moves Forward - GuruFocus

Feb 03, 2026

Feb 02, 2026

Avidity Biosciences Sets February 15, 2026 as Record Date for Planned Spin-Off - geneonline.com

Feb 02, 2026

Feb 02, 2026

Avidity holders to get Atrium cardiology SpinCo shares in Novartis deal - stocktitan.net

Feb 02, 2026

Feb 02, 2026

Avidity Biosciences says record date set for February 12, 2026 for spin-off - marketscreener.com

Feb 02, 2026

Feb 02, 2026

Avidity Biosciences Says Record Date Set For February 12, 2026 For Spin-Off - TradingView

Feb 02, 2026

Feb 02, 2026

Avidity Biosciences Announces Share Distribution for Spin-Off - Intellectia AI

Feb 02, 2026

Feb 02, 2026

Avidity Biosciences (NASDAQ:RNA) Hits New 12-Month HighHere's What Happened - MarketBeat

Feb 02, 2026

Feb 02, 2026

Avidity Biosciences stock hits all-time high at 72.74 USD - Investing.com

Feb 02, 2026

Feb 02, 2026

New York State Common Retirement Fund Purchases 120,365 Shares of Avidity Biosciences, Inc. $RNA - MarketBeat

Feb 02, 2026

Feb 01, 2026

Atle Fund Management AB Makes New Investment in Avidity Biosciences, Inc. $RNA - MarketBeat

Feb 01, 2026

Jan 31, 2026

Halper Sadeh LLC Encourages TWO, RNA, CVBF, TBN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Jan 31, 2026

Jan 30, 2026

Avidity Biosciences Sets February Vote on $72-per-Share Novartis Takeover and Cardiology Spin-Off - TipRanks

Jan 30, 2026

Jan 29, 2026

Risk Recap: Whats the fair value of Avidity Biosciences Inc stock2025 Investor Takeaways & Real-Time Volume Spike Alerts - baoquankhu1.vn

Jan 29, 2026

Jan 29, 2026

Price Action: Will Avidity Biosciences Inc announce a stock splitJuly 2025 Decliners & Growth Focused Stock Reports - baoquankhu1.vn

Jan 29, 2026

Jan 29, 2026

Mutual of America Capital Management LLC Trims Stake in Avidity Biosciences, Inc. $RNA - MarketBeat

Jan 29, 2026

Jan 27, 2026

EFG Asset Management North America Corp. Reduces Holdings in Avidity Biosciences, Inc. $RNA - MarketBeat

Jan 27, 2026

Jan 26, 2026

Avidity Biosciences, Inc. (RNA) Stock Analysis: A Biotech Powerhouse with 434% Revenue Growth and Promising Clinical Trials - DirectorsTalk Interviews

Jan 26, 2026

Jan 24, 2026

Aug Momentum: Will Avidity Biosciences Inc outperform tech stocksJuly 2025 Review & Stepwise Trade Execution Plans - baoquankhu1.vn

Jan 24, 2026

Jan 24, 2026

Avidity Biosciences CSO sells $473k in RNA stock By Investing.com - Investing.com South Africa

Jan 24, 2026

Jan 24, 2026

Avidity Biosciences CFO MacLean sells $329k in stock By Investing.com - Investing.com Australia

Jan 24, 2026

Jan 24, 2026

Avidity Biosciences CMO sells $354k in stock By Investing.com - Investing.com South Africa

Jan 24, 2026

Jan 23, 2026

Avidity Biosciences Insider Sold Shares Worth $473,388, According to a Recent SEC Filing - 富途资讯

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences CEO Boyce sells $1.04 million in stock By Investing.com - Investing.com Canada

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences (NASDAQ:RNA) Insider Sells $473,388.30 in Stock - MarketBeat

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences (NASDAQ:RNA) Insider Sells $354,642.75 in Stock - MarketBeat

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences (NASDAQ:RNA) CEO Sells $1,042,338.15 in Stock - MarketBeat

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences (NASDAQ:RNA) Insider Teresa Mccarthy Sells 2,929 Shares - MarketBeat

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences CMO sells $354k in stock - Investing.com

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences CSO sells $473k in RNA stock - Investing.com

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences stock hits all-time high at $72.70 By Investing.com - Investing.com Australia

Jan 23, 2026

Jan 23, 2026

Avidity Biosciences CFO MacLean sells $329k in stock - Investing.com

Jan 23, 2026

Jan 22, 2026

Avidity Biosciences (NASDAQ:RNA) Reaches New 12-Month HighHere's What Happened - MarketBeat

Jan 22, 2026

Jan 22, 2026

Avidity Biosciences stock hits all-time high at $72.70 - Investing.com

Jan 22, 2026